$2.50
-0.015-0.6%
Last update: Nov 10, 10:15 AM
Protara Therapeutics Inc
TARANASDAQ
The average analyst price target for Protara Therapeutics is $22.64, 807.4% above the current price. Of 8 analysts, 8 rate it Buy. Targets range from $12 to $28. The latest change came on May 20, 2026, when Oppenheimer raised its price target on Protara Therapeutics from $25 to $28 and kept an Outperform rating.
Price Target Range — 9 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
